TL;DR
The FDA’s decision to accept AI drug testing is less about scientific progress and more about opening the floodgates for hype and scams. Investors beware: this AI drug mania smells like the next big market crash.
Story
AI drug mania. Sounds like a casino, right? Let’s unpack why this FDA announcement smells fishy.
The FDA says they’re replacing animal testing with AI. That’s like swapping a lab rat for a magic 8-ball. Sure, simulations are cheaper, but are they reliable? Nope. Not even close.
Remember Theranos? They promised blood tests with a pinprick, using tech that didn’t exist. This AI drug thing feels eerily similar.
Here’s the scammy part:
- Pharma companies rush to “AI drug discovery” stocks. Think $ABSCI, $RXRX, $SDGR.
- Prices skyrocket. People FOMO in.
- The hype fades. AI fails to replace real testing. Stock prices crash.
- Investors lose their shirts. Again.
‣ FOMO: Fear of missing out. ‣ $ABSCI, $RXRX, $SDGR: Stock tickers for companies claiming to do AI drug discovery.
This isn’t new. Remember the 2000 dot-com bubble? Or the 2008 housing crisis? Greed, fueled by hype, always ends badly.
The FDA announcement is a gift to scammers. It’s a green light for companies to overhype their AI capabilities and cash in on the mania.
Some experts even doubt AI can ever replace animal testing. See? Snake oil.
The FDA says companies with “strong non-animal safety data” might get faster reviews. That’s like saying, “Show us your unicorn, and we’ll approve your drug tomorrow.” It’s a loophole big enough to drive a truck through. Bribery, anyone?
‣ Unicorn: A mythical creature; something that doesn’t exist.
Don’t be fooled. This isn’t progress; it’s a casino where the house always wins.
Advice
If it sounds too good to be true, it probably is. Don’t fall for the AI drug hype. Stick to sound investments, not speculative bubbles.
Source
https://www.reddit.com/r/wallstreetbets/comments/1jz3ksy/ai_drug_sector_mania_is_starting_on_fda/